We are live on ! Find out more
LABD icon

Direxion Daily S&P Biotech Bear 3X ETF
LABD

6 hedge funds and large institutions have $1.45M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $8.34M

50% more funds holding

Funds holding: 4 → 6 (+2)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

69% less capital invested

Capital invested by funds: $4.67M → $1.45M (-$3.23M)

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
–
Calls
$13.5M
Puts
$8.34M
Net Calls
+$5.2M
Net Calls Change
-$4.34M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$242K
2
Simplex Trading
Simplex Trading
Illinois
+$242K
3
UBS Group
UBS Group
Switzerland
+$80.6K

Top Sellers

Rank Fund Capital Flow
1
FTUS
Flow Traders U.S.
New York
-$1.77M
2
Jane Street
Jane Street
New York
-$564K
3
CG
Cutler Group
California
-$161K

LABD Hedge Fund Activity: Q2 2016 in Review

6 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q2 2016, worth a combined $1.45M — down 69% from $4.67M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new LABD positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $242K. The largest seller was Flow Traders U.S., cutting an estimated $1.77M.

  • 6 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q2 2016, up from 4 in Q1 2016.
  • Funds reported $1.45M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q2 2016, down 69% quarter-over-quarter.
  • 2 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q2 2016 and 0 closed out, a net change of +2 holders.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q2 2016 was Morgan Stanley, an estimated $242K added.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q2 2016 was Flow Traders U.S., an estimated $1.77M sold.

Based on aggregated 13F filings for Q2 2016.